Concepedia

Author

Yan Lin

The University of Texas MD Anderson Cancer Center

Also Known As

Y. Lin, Yan H. Lin, Yan Heather Lin, Yan Lin, Yuan-Leng Lin, Yu‐Qing Su

43

Publications

627

Citations

12

H-Index

40

Concepts

All Affiliations

The University of Texas MD Anderson Cancer CenterFujian Medical UniversityFujian Provincial Hospital
YL

About

Yan Lin is an author at The University of Texas MD Anderson Cancer Center specializing in medicine, pharmacotherapy, and radiation oncology.

Top Concepts

#ConceptH-IndexPublicationsCitations

1

Medicine

6

6

436

2

Immunology

3

3

237

3

Health Sciences

1

1

15

4

Cell Biology

1

1

190

5

Neurology

1

1

190

Yan Lin

×

12

Publications

572

Citations

11

H-Index

YearCitations

TREM2 ameliorates neuroinflammatory response and cognitive impairment via PI3K/AKT/FoxO3a signaling pathway in Alzheimer’s disease mice

Yaping Wang, Yan Lin, Linhan Wang,

Aging

2020

190

Phase II Trial of Concurrent Atezolizumab With Chemoradiation for Unresectable NSCLC

Steven H. Lin, Yan Lin, Luyang Yao,

Journal of Thoracic Oncology

2019

135

Outcomes after Treatment of Metaplastic Versus Other Breast Cancer Subtypes

Amy C. Moreno, Yan Lin, Isabelle Bedrosian,

Journal of Cancer

2020

56

Incidence of Atypical Femur Fractures in Cancer Patients: The MD Anderson Cancer Center Experience

Beatrice J. Edwards, Ming Sun, Dennis P. West,

Journal of Bone and Mineral Research

2016

49

miR‑34a increases inflammation and oxidative stress levels in patients with necrotizing enterocolitis by downregulating SIRT1 expression

Hui Zhu, Yan Lin, Yongle Liu

Molecular Medicine Reports

2021

30

Maternal nicotine exposure aggravates metabolic associated fatty liver disease via PI3K/Akt signaling in adult offspring mice

S. Huang, Shu‐qiang Chen, Yan Lin,

Liver International

2021

23

Correlation between ischemia-modified albumin level and coronary collateral circulation

Xin Chen, Yan Lin, Lihua Tian,

BMC Cardiovascular Disorders

2020

18

DETERRED: PD-L1 blockade to evaluate the safety of lung cancer therapy using carboplatin, paclitaxel, and radiation combined with MPDL3280A (atezolizumab).

Steven H. Lin, Yan Lin, Justina Price,

Journal of Clinical Oncology

2017

17

Use of regional nodal irradiation and its association with survival for women with high-risk, early stage breast cancer: A National Cancer Database analysis

Amy C. Moreno, Yan Lin, Isabelle Bedrosian,

Advances in Radiation Oncology

2017

16

Phase II trial combining atezolizumab concurrently with chemoradiation therapy in locally advanced non-small cell lung cancer.

Steven H. Lin, Yan Lin, Isabel Mok,

Journal of Clinical Oncology

2019

15

Page 1